Weight loss medications are prescription drugs that help people lose weight by reducing appetite, slowing digestion, or blocking fat absorption. They’re typically prescribed for adults with a BMI of 30 or higher, or a BMI of 27 or higher if they also have a weight-related condition like high blood pressure or type 2 diabetes. The landscape has changed dramatically in recent years, with newer injectable medications producing weight loss of 15% to 20% of body weight in clinical trials.
How Weight Loss Medications Work
Modern weight loss drugs fall into a few distinct categories based on how they act in the body. The most widely discussed are GLP-1 receptor agonists, which mimic a gut hormone your body naturally produces after eating. These drugs work on two fronts: in the brain, they dial down hunger signals and increase feelings of fullness, while in the digestive system, they slow the rate at which food leaves your stomach. That slower gastric emptying means you feel satisfied longer after a meal and naturally eat less.
Older medications take different approaches. One class blocks enzymes in the gut that break down dietary fat, preventing about 30% of the fat you eat from being absorbed. That unabsorbed fat passes through your system, which can cause oily stools and digestive discomfort but doesn’t affect your brain chemistry. Another category uses stimulant-like compounds that suppress appetite directly and may also influence how your body processes energy. These oral options have been available for years and remain in use, though the newer injectables tend to produce larger results.
The Newer Injectable Medications
The drugs getting the most attention right now are semaglutide (sold as Wegovy) and tirzepatide (sold as Zepbound). Both are self-administered weekly injections.
Semaglutide targets a single gut hormone receptor. In clinical trials over 72 weeks, participants on the standard 2.4 mg dose lost an average of 15.6% of their body weight, while those on a higher 7.2 mg dose lost 18.7%, compared to just 3.9% with a placebo. Tirzepatide works on two hormone receptors simultaneously, and it produced even larger results in its pivotal trial: participants lost an average of 15% at the lowest dose, 19.5% at the middle dose, and 20.9% at the highest dose over 72 weeks. For someone weighing 250 pounds, that highest-dose result translates to roughly 52 pounds.
These medications aren’t taken at full strength from the start. Both follow a gradual dose escalation schedule, typically increasing every four weeks. Wegovy starts at 0.25 mg weekly and climbs through several steps before reaching the maintenance dose of 2.4 mg. Zepbound starts at 2.5 mg and can be increased up to 15 mg. This slow ramp-up helps your body adjust and reduces the severity of side effects.
Oral Prescription Options
Not all weight loss medications require injections. Phentermine combined with topiramate (sold as Qsymia) is an oral option that works by suppressing appetite through stimulant and neurological pathways. At the maximum dose, patients in clinical trials lost an average of 11% of their body weight after one year. The lower dose produced 7% to 8% weight loss. Common side effects include dry mouth, constipation, tingling sensations, insomnia, and altered taste. These effects are dose-dependent, occurring in 10% to 20% of patients at higher doses.
Orlistat (available as Xenical by prescription or over the counter as Alli at a lower dose) takes a completely different approach by blocking fat absorption in the gut. It’s less effective overall than the other options but doesn’t carry the same neurological or cardiovascular considerations. The trade-off is gastrointestinal side effects, especially if you eat high-fat meals while taking it.
Side Effects to Expect
The most common side effects of GLP-1 medications are gastrointestinal: nausea, vomiting, diarrhea, and constipation. These affect roughly 50% to 60% of patients, most often during the early weeks of treatment or when the dose increases. For most people, they fade as the body adjusts. The gradual dose titration schedule exists specifically to ease this transition.
The stimulant-based oral medications carry a different side effect profile, including increased heart rate, insomnia, and irritability. The FDA has required ongoing monitoring of cardiovascular safety for phentermine-topiramate because clinical trials showed a dose-dependent increase in heart rate, though no increased risk of heart attack or valve disease was found in study participants.
Who Should Not Take These Medications
GLP-1 medications carry a specific warning for anyone with a personal or family history of medullary thyroid carcinoma, a rare type of thyroid cancer. The same restriction applies to people with a genetic condition called Multiple Endocrine Neoplasia Syndrome type 2, which carries a very high risk of developing that same cancer. If you have a common thyroid condition like hypothyroidism, that alone is not a contraindication, but the distinction matters enough to discuss with a prescriber.
Phentermine-topiramate is contraindicated in pregnancy due to the risk of birth defects, and it hasn’t been studied in people with existing heart problems. Orlistat can interfere with the absorption of fat-soluble vitamins and certain medications, so timing and supplementation become important.
What the Experience Actually Looks Like
Starting a weight loss medication isn’t like flipping a switch. The first few weeks at a low dose may produce modest appetite changes and some nausea. As the dose increases monthly, appetite suppression becomes more noticeable. Most people describe it as a quieting of “food noise,” the constant background thoughts about eating that many people with obesity experience. Meals become smaller not through willpower but because fullness arrives sooner and lasts longer.
The weight loss itself follows a curve. The steepest drops typically happen in the first six to nine months, with the rate gradually slowing as you approach a new stable weight. Clinical trials ran for about 72 weeks (roughly 16 to 17 months), and participants were still losing weight at the end of that period, though more slowly. One important reality: studies consistently show that weight tends to return after stopping the medication, which is why many providers treat these as long-term prescriptions rather than short courses.
These medications also work best alongside changes to diet and physical activity. Every major clinical trial paired the drugs with lifestyle counseling, and the results reflect that combination. The medication makes it easier to eat less and move more, but it doesn’t replace those behaviors entirely.
Cost and Access
The biggest practical barrier for many people is cost. The newer injectable medications carry list prices that can exceed $1,000 per month without insurance, and coverage varies widely between plans. Some insurers cover weight loss medications only for patients with specific comorbidities like type 2 diabetes, while others exclude them entirely. Older options like phentermine are available as generics and cost significantly less, though they produce smaller results. Orlistat’s lower-dose version is available over the counter without a prescription, making it the most accessible option, though also the least effective.
Demand for the newer injectables has also created intermittent supply shortages, which can interrupt treatment. If you’re considering starting one of these medications, it’s worth asking about availability and what happens if your specific dose is temporarily unavailable.